Cargando…
Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area
BACKGROUND: Type I Helicobacter pylori (H. pylori) infection causes severe gastric inflammation and is a predisposing factor for gastric carcinogenesis. However, its infection status in stepwise gastric disease progression in this gastric cancer prevalent area has not been evaluated; it is also not...
Autores principales: | Yuan, Lin, Zhao, Jun-Bo, Zhou, Ying-Lei, Qi, Ya-Bin, Guo, Qiong-Ya, Zhang, Hai-Hui, Khan, Muhammad Noman, Lan, Ling, Jia, Chang-He, Zhang, Yan-Rui, Ding, Song-Ze |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366059/ https://www.ncbi.nlm.nih.gov/pubmed/32742135 http://dx.doi.org/10.3748/wjg.v26.i25.3673 |
Ejemplares similares
-
Association of serum pepsinogens and gastrin-17 with Helicobacter pylori infection assessed by urea breath test
por: Zhou, Jun-peng, et al.
Publicado: (2022) -
Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17
levels for population-based screening for early-stage gastric
cancer
por: Wang, Yaping, et al.
Publicado: (2020) -
Helicobacter pylori antibody and pepsinogen testing for predicting gastric microbiome abundance
por: Choi, Saemi, et al.
Publicado: (2019) -
Pepsinogen I and II, Gastrin and Cag A Serum Levels in Shiraz
por: Shamsdin, Seyedeh Azra, et al.
Publicado: (2011) -
Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran
por: Hosseini, Mosalreza, et al.
Publicado: (2013)